Please login or register to print this page.

VIEW TAGS

Articles tagged ‘NICE’

May 28, 2015

NOAC news

Apixaban
The National Institute for Health and Care Excellence (NICE) has issued Final Appraisal Determination (FAD) recommending the NOAC (non-vitamin K oral anticoagulant) apixaban (Eliquis®) as an option for the treatment and prevention of recurrent deep vein thrombosis (DVT) and/or pulmonary embolism (PE) in adults.

read more

March 27, 2015

Apixaban recommended for treating and preventing DVT

Apixaban has been recommended as an option for treating and preventing venous thromboembolism (VTE) in adults in draft guidance1 published recently by the National Institute for Health and Care Excellence (NICE)

read more

July 30, 2013

Large scale audit of nurse-led clinics in the UK

The number of nurse-led clinics in cardiac care have grown enormously in the UK since the late 1990s. Nurses generally, but not exclusively, practice at what is known as an advanced practice level, demonstrating a variety of skills to meet the needs of the cardiac patient in their clinics.

read more

March 9, 2012

NICE updates evidence on VTE risk

Improved understanding of venous thromboembolism (VTE) and the best interventions for it are the focus of the latest Evidence Update1 from NHS Evidence. The update summarises new data relevant to National Institute for Health and Clinical Excellence (NICE) clinical guideline 92.

read more

September 20, 2010

Dronedarone approved for use in England and Wales

The National Institute for Health and Clinical Excellence (NICE) has published final guidance on the use of Multaq® (dronedarone) for the treatment of atrial fibrillation (AF).

read more

July 22, 2010

Positive NICE Final Appraisal For Dronedarone

The National Institute for Health and Clinical Excellence (NICE) has issued its final appraisal determination on dronedarone (Multaq) recommending the drug as an option for non-permanent atrial fibrillation (AF) in selected patients. (1)

read more

April 9, 2010

Dronedarone gets thumbs up from NICE in New Appraisal Consultation Document

The National Institute for Health and Clinical Excellence (NICE) in England and Wales, has just published a new appraisal consultation document (ACD)1 for Multaq® (dronedarone) indicating its intention to recommend its use for the management of patients with atrial fibrillation (AF).

read more

January 20, 2010

NICE publishes draft recommendations on the management of chronic heart failure in adults

NICE is in the process of updating its clinical guideline on the management of chronic heart failure in adults and has now published its draft recommendations for public consultation. Since the original guideline was published in 2003, new high-quality evidence from randomised controlled trials in diagnosis, treatment and monitoring have been published. This partial update will ensure that the recommendations take into account the new evidence available.

read more

Members Area

Log in or Register now.

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

ENDORSED BY

  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.